Skip to main content
. 2022 Jun 2;15:916249. doi: 10.3389/fnmol.2022.916249

FIGURE 6.

FIGURE 6

Necrosulfonamide (NSA) improved neurological functions after intracerebral hemorrhage (ICH). (A) Quantification of focal neurological deficit at 3 days after ICH (n = 6, per group). (B) Quantification of corner test scores at 1 day and 3 days after ICH (n = 11, per group). Data are shown as mean ± SD, *p < 0.05, **p < 0.01, ****p < 0.0001, #p < 0.05, ####p < 0.0001.